The risks associated with alteplase therapy do not appear to be higher in selected patients aged 80 years with acute ischaemic stroke, compared with younger patients

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1228, 2000-01, pp. : 13-13

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Acute Ischaemic Stroke in Patients Aged 80 Years and Older: Focus on the Tolerability of Thrombolytic Agents

By Poppe Alexandre Y.   Hill Michael D.  

Drugs & Aging, Vol. 25, Iss. 2, 2008-01 ,pp. : 95-103

Adis International

Access to resources Recommend Favorite

Intravenous Thrombolysis with rt-PA in Acute Stroke Patients Aged ≥80 Years

By  

Letters in Drug Design & Discovery, Vol. 5, Iss. 3, 2008-04 ,pp. : 209-213

Bentham Science Publishers

Access to resources Recommend Favorite

Alteplase underused in acute ischaemic stroke

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 331, 2001-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Intravenous alteplase for acute ischaemic stroke

By Larrue Vincent  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 15, 2005-12 ,pp. : 2699-2709

Informa Healthcare

Access to resources Recommend Favorite

Alteplase underused in acute ischaemic stroke

By  

Inpharma, Vol. 1, Iss. 1306, 2001-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite